Business

Senate Majority Leader Mitch McConnell of Ky., smiles as he talks to reporters on Capitol Hill in Washington, Tuesday, July 25, 2017, after Vice President Mike Pence broke a 50-50 tie to start debating Republican legislation to tear down much of the Obama health care law. (AP Photo/Jacquelyn Martin)
July 26, 2017 - 12:12 am
WASHINGTON (AP) — Prodded by President Donald Trump, a bitterly divided Senate voted, at last, Tuesday to move forward with the Republicans' long-promised legislation to repeal and replace "Obamacare." There was high drama as Sen. John McCain returned to the Capitol for the first time after being...
Read More
Senate Majority Leader Mitch McConnell of Ky., smiles as he talks to reporters on Capitol Hill in Washington, Tuesday, July 25, 2017, after Vice President Mike Pence broke a 50-50 tie to start debating Republican legislation to tear down much of the Obama health care law. (AP Photo/Jacquelyn Martin)
July 26, 2017 - 12:12 am
WASHINGTON (AP) — Prodded by President Donald Trump, a bitterly divided Senate voted, at last, Tuesday to move forward with the Republicans' long-promised legislation to repeal and replace "Obamacare." There was high drama as Sen. John McCain returned to the Capitol for the first time after being...
Read More
FILE - This Tuesday, Oct. 25, 2016, file photo shows the New York Stock Exchange, in lower Manhattan. Stock markets turned higher on Tuesday, July 25, 2017, as investors monitored a slew of corporate earnings reports. A meeting of the Federal Reserve and caution over potential twists and turns in U.S. politics kept most indexes trading within a narrow range. (AP Photo/Mary Altaffer, File)
July 25, 2017 - 11:41 pm
HONG KONG (AP) — Asian stock markets are mixed Wednesday, with upward momentum from a record day on Wall Street and buoyant oil prices offset by investor caution ahead of the Fed's upcoming interest rate decision. KEEPING SCORE: Japan's benchmark Nikkei 225 index climbed 0.5 percent to 20,055.29...
Read More
FILE - This Tuesday, Oct. 25, 2016, file photo shows the New York Stock Exchange, in lower Manhattan. Stock markets turned higher on Tuesday, July 25, 2017, as investors monitored a slew of corporate earnings reports. A meeting of the Federal Reserve and caution over potential twists and turns in U.S. politics kept most indexes trading within a narrow range. (AP Photo/Mary Altaffer, File)
July 25, 2017 - 11:41 pm
HONG KONG (AP) — Asian stock markets are mixed Wednesday, with upward momentum from a record day on Wall Street and buoyant oil prices offset by investor caution ahead of the Fed's upcoming interest rate decision. KEEPING SCORE: Japan's benchmark Nikkei 225 index climbed 0.5 percent to 20,055.29...
Read More
FILE - This April 7, 1998 file photo shows capsules of the drug thalidomide at the Celgene Corp. in Warren, N.J, printed with a symbol warning pregnant or soon-to-be pregnant women against use of the drug that had caused thousands of infant deformities. Celgene has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud by promoting a drug for leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday, July 25, 2017. (AP Photo/Mike Derer, File)
July 25, 2017 - 10:59 pm
LOS ANGELES (AP) — Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another therapy for unapproved cancer treatments, federal...
Read More
FILE - This April 7, 1998 file photo shows capsules of the drug thalidomide at the Celgene Corp. in Warren, N.J, printed with a symbol warning pregnant or soon-to-be pregnant women against use of the drug that had caused thousands of infant deformities. Celgene has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud by promoting a drug for leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday, July 25, 2017. (AP Photo/Mike Derer, File)
July 25, 2017 - 10:59 pm
LOS ANGELES (AP) — Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another therapy for unapproved cancer treatments, federal...
Read More
FILE - This April 7, 1998 file photo shows capsules of the drug thalidomide at the Celgene Corp. in Warren, N.J, printed with a symbol warning pregnant or soon-to-be pregnant women against use of the drug that had caused thousands of infant deformities. Celgene has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud by promoting a drug for leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday, July 25, 2017. (AP Photo/Mike Derer, File)
July 25, 2017 - 10:58 pm
LOS ANGELES (AP) — Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another therapy for unapproved cancer treatments, federal...
Read More
FILE - This April 7, 1998 file photo shows capsules of the drug thalidomide at the Celgene Corp. in Warren, N.J, printed with a symbol warning pregnant or soon-to-be pregnant women against use of the drug that had caused thousands of infant deformities. Celgene has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud by promoting a drug for leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday, July 25, 2017. (AP Photo/Mike Derer, File)
July 25, 2017 - 10:58 pm
LOS ANGELES (AP) — Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another therapy for unapproved cancer treatments, federal...
Read More
Sen. John McCain, R-Ariz. arrives on Capitol Hill in Washington, Tuesday, July 25, 2017, as the Senate was to vote on moving head on health care with the goal of erasing much of Barack Obama's law. (AP Photo/Andrew Harnik)
July 25, 2017 - 10:09 pm
WASHINGTON (AP) — The Latest on the effort by congressional Republicans to pass a health care bill (all times local): 10 p.m. The Senate has blocked a wide-ranging proposal by Republicans to repeal much of former President Barack Obama's health care law and replace it with a more restrictive plan...
Read More
Sen. John McCain, R-Ariz. arrives on Capitol Hill in Washington, Tuesday, July 25, 2017, as the Senate was to vote on moving head on health care with the goal of erasing much of Barack Obama's law. (AP Photo/Andrew Harnik)
July 25, 2017 - 10:09 pm
WASHINGTON (AP) — The Latest on the effort by congressional Republicans to pass a health care bill (all times local): 10 p.m. The Senate has blocked a wide-ranging proposal by Republicans to repeal much of former President Barack Obama's health care law and replace it with a more restrictive plan...
Read More

Pages